S'abonner

The Rapid Evaluation of COVID-19 Vaccination in Emergency Departments for Underserved Patients Study - 23/09/21

Doi : 10.1016/j.annemergmed.2021.05.026 
Robert M. Rodriguez, MD a, , Jesus R. Torres, MD, MPH b, Anna Marie Chang, MD, MSCE c, Adrianne N. Haggins, MD, MS d, Stephanie A. Eucker, MD, PhD e, Kelli N. O’Laughlin, MD, MPH f, Erik Anderson, MD g, Daniel G. Miller, MD h, R. Gentry Wilkerson, MD i, Martina Caldwell, MD, MS j, Stephen C. Lim, MD k, Ali S. Raja, MD, MPH l, Brigitte M. Baumann, MD, MSCE m, Joseph Graterol, MD a, Vidya Eswaran, MD a, Brian Chinnock, MD n

The REVVED UP Investigators

Graham Nichol, MD, MPH, Blair A. Parry, Alaina Hunt, BA, Morgan Kelly, BS, Breena R. Taira, MD, MPH, Michael Pham, Joshua Tiao, MD, Kyra Lasko, Mayuri Aivale, MPH, Alex Farthing, BA, Nicole Byl, BA, Virginia Chan, BS, Nancy Anaya, MD, Angela H. Wong, BA, Bhanu Chadalawada, MS, Anna Tupetz, PT, DPT

a Department of Emergency Medicine, University of California San Francisco, San Francisco, CA 
b Department of Emergency Medicine, Olive View UCLA Medical Center–University of California Los Angeles School of Medicine, Los Angeles, CA 
c Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 
d Department of Emergency Medicine, University of Michigan, Ann Arbor, MI 
e Division of Emergency Medicine, Department of Surgery, Duke University, Durham, NC 
f Departments of Emergency Medicine and Global Health, University of Washington, Seattle, WA 
g Department of Emergency Medicine, Highland Hospital-Alameda Health System, Oakland, CA 
h Department of Emergency Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA 
i Department of Emergency Medicine, University of Maryland School of Medicine, College Park, MD 
j Department of Emergency Medicine, Henry Ford Hospital, Detroit, MI 
k Section of Emergency Medicine, University Medical Center New Orleans, Louisiana State University Health Sciences Center, New Orleans, LA 
l Department of Emergency Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 
m Department of Emergency Medicine, Cooper Medical School of Rowan University, Camden, NJ 
n Department of Emergency Medicine, University of California San Francisco Fresno, Fresno, CA 

Corresponding Author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Study objective

Emergency departments (EDs) often serve vulnerable populations who may lack primary care and have suffered disproportionate COVID-19 pandemic effects. Comparing patients having and lacking a regular source of medical care and other ED patient characteristics, we assessed COVID-19 vaccine hesitancy, reasons for not wanting the vaccine, perceived access to vaccine sites, and willingness to get the vaccine as part of ED care.

Methods

This was a cross-sectional survey conducted from December 10, 2020, to March 7, 2021, at 15 safety net US EDs. Primary outcomes were COVID-19 vaccine hesitancy, reasons for vaccine hesitancy, and sites (including EDs) for potential COVID-19 vaccine receipt.

Results

Of 2,575 patients approached, 2,301 (89.4%) participated. Of the 18.4% of respondents who lacked a regular source of medical care, 65% used the ED as their usual source of health care. The overall rate of vaccine hesitancy was 39%; the range among the 15 sites was 28% to 58%. Respondents who lacked a regular source of medical care were more commonly vaccine hesitant than those who had a regular source of medical care (47% versus 38%, 9% difference, 95% confidence interval 4% to 14%). Other characteristics associated with greater vaccine hesitancy were younger age, female sex, Black race, Latinx ethnicity, and not having received an influenza vaccine in the past 5 years. Of the 61% who would accept a COVID-19 vaccine, 21% stated that they lacked a primary physician or clinic at which to receive it; the vast majority (95%) of these respondents would accept the COVID-19 vaccine as part of their care in the ED.

Conclusion

ED patients who lack a regular source of medical care are particularly hesitant regarding COVID-19 vaccination. Most COVID-19 vaccine acceptors would accept it as part of their care in the ED. EDs may play pivotal roles in COVID-19 vaccine messaging and delivery to highly vulnerable populations.

Le texte complet de cet article est disponible en PDF.

Plan


 Please see page 503 for the Editor’s Capsule Summary of this article.
 Supervising editor: Donald M. Yealy, MD. Specific detailed information about possible conflict of interest for individual editors is available at editors.
 Author contributions: RMR and JT designed the study and performed data analysis. All authors were responsible for study implementation, data acquisition, and manuscript preparation. RMR takes responsibility for the paper as a whole.
 All authors attest to meeting the four ICMJE.org authorship criteria:(1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (seewww.icmje.org). The authors have stated that no such relationships exist.
 Readers: click on the link to go directly to a survey in which you can provide VWDCY8K to Annals on this particular article.
 A podcast for this article is available at www.annemergmed.com.


© 2021  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 78 - N° 4

P. 502-510 - octobre 2021 Retour au numéro
Article précédent Article précédent
  • Female With Hypotension
  • Shilpa Kolli, Maninder Singh, Gordon Chien
| Article suivant Article suivant
  • Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination
  • Richard Todd Clark, Lee Johnson, Jamie Billotti, Georgia Foulds, Taryn Ketels, Kennon Heard, Emilie Calvello Hynes

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.